Research news
Parkinson’s UK led consortium is using big data to accelerate new treatment options, aiming to unlock a cure for Parkinson’s.
The Beech Band, designed by Carl Beech, is a wearable device showing promising signs of being able to manage symptoms including speech issues, anxiety and gait.
A small study shows that adaptive deep brain stimulation is better than the standard version at controlling movement symptoms day and night for people with Parkinson’s.
We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.
The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.
We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson’s.
We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson’s and to start exploring its potential benefits.
Parkinson's UK is funding researchers to develop a potential set of drugs against a new target for people with Parkinson's.
Research co-funded by Parkinson’s UK finds a new way to potentially improve diagnosis and monitoring of Parkinson’s.
We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.